{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:48Z","timestamp":1707524568057},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,14]]},"DOI":"10.7759\/cureus.22216","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T02:23:40Z","timestamp":1644891820000},"source":"Crossref","is-referenced-by-count":1,"title":["Endogenous Endophthalmitis From Methicillin-Resistant Staphylococcus aureus Bacteremia Treated With Ceftaroline"],"prefix":"10.7759","author":[{"given":"Daniel","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola A","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Silverstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Koff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2013.03.008","article-title":"Staphylococcus aureus bacteremia, risk factors, complications, and management","volume":"29","author":"Keynan Y","year":"2013","unstructured":"Keynan Y, Rubinstein E. Staphylococcus aureus bacteremia, risk factors, complications, and management. Crit Care Clin. 2013, 29:547-62. 10.1016\/j.ccc.2013.03.008","journal-title":"Crit Care Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2015.1020173","article-title":"Endogenous endophthalmitis in patients with MRSA septicemia: a case series and review of literature","volume":"24","author":"Shenoy SB","year":"2016","unstructured":"Shenoy SB, Thotakura M, Kamath Y, Bekur R. Endogenous endophthalmitis in patients with MRSA septicemia: a case series and review of literature. Ocul Immunol Inflamm. 2016, 24:515-20. 10.3109\/09273948.2015.1020173","journal-title":"Ocul Immunol Inflamm"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.06.025","article-title":"Off-label use of ceftaroline fosamil: a systematic review","volume":"54","author":"Pani A","year":"2019","unstructured":"Pani A, Colombo F, Agnelli F, Frantellizzi V, Baratta F, Pastori D, Scaglione F. Off-label use of ceftaroline fosamil: a systematic review. Int J Antimicrob Agents. 2019, 54:562-71. 10.1016\/j.ijantimicag.2019.06.025","journal-title":"Int J Antimicrob Agents"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.01.017","article-title":"Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics","volume":"25","author":"Brockhaus L","year":"2019","unstructured":"Brockhaus L, Goldblum D, Eggenschwiler L, Zimmerli S, Marzolini C. Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics. Clin Microbiol Infect. 2019, 25:1364-9. 10.1016\/j.cmi.2019.01.017","journal-title":"Clin Microbiol Infect"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00286-13","article-title":"Efficacy of ceftaroline fosamil against penicillin-sensitive and -resistant streptococcus pneumoniae in an experimental rabbit meningitis model","volume":"57","author":"Cottagnoud P","year":"2013","unstructured":"Cottagnoud P, Cottagnoud M, Acosta F, Stucki A. Efficacy of ceftaroline fosamil against penicillin-sensitive and -resistant streptococcus pneumoniae in an experimental rabbit meningitis model. Antimicrob Agents Chemother. 2013, 57:4653-5. 10.1128\/AAC.00286-13","journal-title":"Antimicrob Agents Chemother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00285-13","article-title":"Efficacy of ceftaroline fosamil against Escherichia coli and Klebsiella pneumoniae strains in a rabbit meningitis model","volume":"57","author":"Stucki A","year":"2013","unstructured":"Stucki A, Acosta F, Cottagnoud M, Cottagnoud P. Efficacy of ceftaroline fosamil against Escherichia coli and Klebsiella pneumoniae strains in a rabbit meningitis model. Antimicrob Agents Chemother. 2013, 57:5808-10. 10.1128\/AAC.00285-13","journal-title":"Antimicrob Agents Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku464","article-title":"Ceftaroline CSF concentrations in a patient with ventriculoperitoneal shunt-related meningitis","volume":"70","author":"Kuriakose SS","year":"2015","unstructured":"Kuriakose SS, Rabbat M, Gallagher JC. Ceftaroline CSF concentrations in a patient with ventriculoperitoneal shunt-related meningitis. J Antimicrob Chemother. 2015, 70:953-4. 10.1093\/jac\/dku464","journal-title":"J Antimicrob Chemother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2016.06.017","article-title":"Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012-2014)","volume":"86","author":"Sader HS","year":"2016","unstructured":"Sader HS, Mendes RE, Jones RN, Flamm RK. Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012-2014). Diagn Microbiol Infect Dis. 2016, 86:76-9. 10.1016\/j.diagmicrobio.2016.06.017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-015-0063-y","article-title":"Endogenous endophthalmitis: diagnosis, management, and prognosis","volume":"5","author":"Sadiq MA","year":"2015","unstructured":"Sadiq MA, Hassan M, Agarwal A, et al.. Endogenous endophthalmitis: diagnosis, management, and prognosis. J Ophthalmic Inflamm Infect. 2015, 5:32. 10.1186\/s12348-015-0063-y","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181ecccf0","article-title":"Endogenous methicillin-resistant Staphylococcus aureus endophthalmitis","volume":"31","author":"Ho V","year":"2011","unstructured":"Ho V, Ho LY, Ranchod TM, Drenser KA, Williams GA, Garretson BR. Endogenous methicillin-resistant Staphylococcus aureus endophthalmitis. Retina. 2011, 31:596-601. 10.1097\/IAE.0b013e3181ecccf0","journal-title":"Retina"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181a3b7a1","article-title":"Endogenous endophthalmitis caused by methicillin-resistant Staphylococcus aureus (MRSA)","volume":"29","author":"Ness T","year":"2009","unstructured":"Ness T, Schneider C. Endogenous endophthalmitis caused by methicillin-resistant Staphylococcus aureus (MRSA). Retina. 2009, 29:831-4. 10.1097\/IAE.0b013e3181a3b7a1","journal-title":"Retina"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/261310","article-title":"An eleven-year retrospective study of endogenous bacterial endophthalmitis","volume":"2015","author":"Nishida T","year":"2015","unstructured":"Nishida T, Ishida K, Niwa Y, Kawakami H, Mochizuki K, Ohkusu K. An eleven-year retrospective study of endogenous bacterial endophthalmitis. J Ophthalmol. 2015, 2015:261310. 10.1155\/2015\/261310","journal-title":"J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2011.02545.x","article-title":"Early intravitreal treatment of endogenous bacterial endophthalmitis","volume":"39","author":"Yonekawa Y","year":"2011","unstructured":"Yonekawa Y, Chan RV, Reddy AK, Pieroni CG, Lee TC, Lee S. Early intravitreal treatment of endogenous bacterial endophthalmitis. Clin Exp Ophthalmol. 2011, 39:771-8. 10.1111\/j.1442-9071.2011.02545.x","journal-title":"Clin Exp Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(14)71959-2","article-title":"Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study","volume":"122","author":"Han DP","year":"1996","unstructured":"Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996, 122:1-17. 10.1016\/s0002-9394(14)71959-2","journal-title":"Am J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1801-3","article-title":"Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment","volume":"21","author":"Hassoun A","year":"2017","unstructured":"Hassoun A, Linden PK, Friedman B. Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment. Crit Care. 2017, 21:211. 10.1186\/s13054-017-1801-3","journal-title":"Crit Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.07.005","article-title":"Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature","volume":"42","author":"Polenakovik HM","year":"2013","unstructured":"Polenakovik HM, Pleiman CM. Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature. Int J Antimicrob Agents. 2013, 42:450-5. 10.1016\/j.ijantimicag.2013.07.005","journal-title":"Int J Antimicrob Agents"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks006","article-title":"Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy","volume":"67","author":"Ho TT","year":"2012","unstructured":"Ho TT, Cadena J, Childs LM, Gonzalez-Velez M, Lewis JS 2nd. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy. J Antimicrob Chemother. 2012, 67:1267-70. 10.1093\/jac\/dks006","journal-title":"J Antimicrob Chemother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/85763-endogenous-endophthalmitis-from-methicillin-resistant-staphylococcus-aureus-bacteremia-treated-with-ceftaroline","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:47Z","timestamp":1707507467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/85763-endogenous-endophthalmitis-from-methicillin-resistant-staphylococcus-aureus-bacteremia-treated-with-ceftaroline"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.22216","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,14]]}}}